Osteoporosis: From osteoscience to neuroscience and beyond
P Kwan - Mechanisms of ageing and development, 2015 - Elsevier
Osteoporosis is well known to be a poly-factorial skeletal disorder characterized by a low
bone mineral density (BMD) at which the risk of developing fracture is remarkably increased …
bone mineral density (BMD) at which the risk of developing fracture is remarkably increased …
Role of epigenomics in bone and cartilage disease
JBJ van Meurs, CG Boer… - Journal of Bone and …, 2019 - academic.oup.com
Phenotypic variation in skeletal traits and diseases is the product of genetic and
environmental factors. Epigenetic mechanisms include information‐containing factors, other …
environmental factors. Epigenetic mechanisms include information‐containing factors, other …
Osteoporosis and bone mass disorders: from gene pathways to treatments
F Rivadeneira, O Mäkitie - Trends in Endocrinology & Metabolism, 2016 - cell.com
Genomic technologies have evolved rapidly contributing to the understanding of diseases.
Genome-wide association studies (GWAS) and whole-exome sequencing have aided the …
Genome-wide association studies (GWAS) and whole-exome sequencing have aided the …
Role of histone modification in the occurrence and development of osteoporosis
P Sun, T Huang, C Huang, Y Wang… - Frontiers in …, 2022 - frontiersin.org
Osteoporosis is a systemic degenerative bone disease characterized by low bone mass and
damage to bone microarchitecture, which increases bone fragility and susceptibility to …
damage to bone microarchitecture, which increases bone fragility and susceptibility to …
Unveiling the mysteries of the genetics of osteoporosis
N Alonso, SH Ralston - Journal of Endocrinological Investigation, 2014 - Springer
Introduction Osteoporosis is a common disease characterised by low bone mineral density
and an increased risk of fragility fractures. Methods We conducted a literature review of …
and an increased risk of fragility fractures. Methods We conducted a literature review of …
Molecular mechanisms and emerging therapeutics for osteoporosis
JY Noh, Y Yang, H Jung - International journal of molecular sciences, 2020 - mdpi.com
Osteoporosis is the most common chronic metabolic bone disease. It has been estimated
that more than 10 million people in the United States and 200 million men and women …
that more than 10 million people in the United States and 200 million men and women …
Genetic control of bone formation
G Karsenty, HM Kronenberg… - Annual Review of Cell …, 2009 - annualreviews.org
In the past few years, our molecular understanding of bone formation has continued to
increase. This review aims to present a comprehensive view of the current state of …
increase. This review aims to present a comprehensive view of the current state of …
Identification of potential pathogenic genes associated with osteoporosis
B Xia, Y Li, J Zhou, B Tian, L Feng - Bone & Joint Research, 2017 - boneandjoint.org.uk
Objectives Osteoporosis is a chronic disease. The aim of this study was to identify key genes
in osteoporosis. Methods Microarray data sets GSE56815 and GSE56814, comprising 67 …
in osteoporosis. Methods Microarray data sets GSE56815 and GSE56814, comprising 67 …
The epigenome at the crossroad between social factors, inflammation, and osteoporosis risk
JA Riancho, SL Brennan-Olsen - Clinical Reviews in Bone and Mineral …, 2017 - Springer
Both genetic and environmental factors are involved in the pathogenesis of osteoporosis
and other skeletal disorders. Epidemiological studies have revealed an influence of a variety …
and other skeletal disorders. Epidemiological studies have revealed an influence of a variety …
Molecular aspects of bone remodeling
AY Parra-Torres, M Valdés-Flores, L Orozco… - Topics in …, 2013 - books.google.com
Bone is a dynamic tissue in constant change; maintenance of bone mass throughout life
relies on the bone remodeling process, which continually replaces old and damaged bone …
relies on the bone remodeling process, which continually replaces old and damaged bone …